Entero Therapeutics, Inc. (ENTO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.69

About Entero Therapeutics, Inc.

Entero Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Boca Raton, Florida, focused on advancing innovative, orally administered therapies to address unmet needs in gastrointestinal diseases. Leveraging its proprietary technology platform, Entero aims to develop targeted treatments that improve patient outcomes and enhance quality of life. With a commitment to scientific excellence and patient-centered solutions, the company is poised to make significant contribution...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Entero Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ENTO pay dividends?

Entero Therapeutics, Inc. (ENTO) does not currently pay a regular dividend.